Search results
Drinking tea may lower the risk of diabetes, heart disease and death, mounting research shows
NBC Universal via AOL· 2 years agoMounting evidence suggests that drinking several cups of tea per day has numerous health benefits,...
Study: Mediterranean Diet Could Help Reduce Type 2 Diabetes Risk
Health via Yahoo News· 11 months agoA new study found the Mediterranean diet may reduce the risk of type 2 diabetes. Experts note that...
Ozempic and Wegovy ‘significantly’ improve blood sugar and weight for the long-term, new study...
Fortune via Yahoo Finance· 7 months agoSemaglutides—weight loss and diabetes injectables like Wegovy, Ozempic, and Rybelsus—significantly...
Consuming Higher Levels of Nitrites and Nitrates May Increase Risk of Type 2 Diabetes—Here Are the...
Eating Well via Yahoo News· 1 year agoWhile genetics play a major role in our overall health outcomes, study after study proves that what...
Ozempic, Wegovy Not Associated With Increased Risk of Suicidal Ideation, Study Finds
Health via Yahoo News· 3 months agoA new study found no association between semaglutide and increased suicidal thoughts. Actually, when...
A Daily Cup of Dark Tea Might Help Improve Blood Sugar and Reduce Diabetes Risk
Health via Yahoo News· 6 months agoNew research found that drinking a cup of dark tea every day may reduce someone's risk of type 2...
Abbott (ABT) Reports Favorable Findings From RELIEF Study
Zacks via Yahoo Finance· 2 years agoThe latest data from the RELIEF Study suggests a lower rate of hospitalizations from serious...
Medtronic (MDT) Gets CE Mark Approval for the New Simplera CGM
Zacks via Yahoo Finance· 7 months agoMedtronic plc MDT recently received CE Mark approval for its new Simplera continuous glucose monitor...
Ditch checking BMI in favour of looking at tummy fat, researchers say
Press Association News via AOL· 2 years agoScrutinising a person’s body mass index (BMI) should be ditched in favour of examining how fat they...
Novo Nordisk's Experimental Diabetes Treatment Achieves Better Blood Sugar Targets Than Insulin...
Benzinga via Yahoo Finance· 2 years agoNovo Nordisk A/S (NYSE: NVO) presented new data from the phase 3a ONWARDS 2 trial of insulin icodec...